影响表观遗传学的药物在炎症性肠病治疗中的研究进展(8)
[60] GUSLANDI M. Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis[J]. J Clin Gastroenterol，2010. DOI：10.1097/MCG.ob013e3181cb4233.
[61] MALDONADO-GOMEZ MX，MARTINEZ I，BOTTACINI F，et al. Stable engraftment of bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome[J]. Cell Host Microbe，2016，20(4)：515-526.
[62] KHORUTS A，DICKSVED J，JANSSON JK，et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea[J]. J Clin Gastroenterol，2010，44(5)：354- 360.
[63] DUVALLET C，ZELLMER C，PANCHAL P，et al. Framework for rational donor selection in fecal microbiota transplant clinical trials[J]. PLoS One，2019. DOI：10.1371/journal.pone.0222881.
[64] WANG ZK，YANG YS，CHEN Y，et al. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease[J]. World J Gastroenterol，2014，20(40)：14805-14820.
(收稿日期：2020-07-07 修回日期：2020-10-22)
(編辑：孙 冰), 百拇医药(伍建中 刘衡 武琦梅 杨旭芹 张成桂 巫秀美 张瑱 葛建)
[61] MALDONADO-GOMEZ MX，MARTINEZ I，BOTTACINI F，et al. Stable engraftment of bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome[J]. Cell Host Microbe，2016，20(4)：515-526.
[62] KHORUTS A，DICKSVED J，JANSSON JK，et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea[J]. J Clin Gastroenterol，2010，44(5)：354- 360.
[63] DUVALLET C，ZELLMER C，PANCHAL P，et al. Framework for rational donor selection in fecal microbiota transplant clinical trials[J]. PLoS One，2019. DOI：10.1371/journal.pone.0222881.
[64] WANG ZK，YANG YS，CHEN Y，et al. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease[J]. World J Gastroenterol，2014，20(40)：14805-14820.
(收稿日期：2020-07-07 修回日期：2020-10-22)
(編辑：孙 冰), 百拇医药(伍建中 刘衡 武琦梅 杨旭芹 张成桂 巫秀美 张瑱 葛建)